Benefit-risk balance for marketed drugs: evaluating safety signals

Benefit-risk balance for marketed drugs: evaluating safety signals

Bewaard in:

Bibliografische gegevens
Coauteur:	Council for International Organizations of Medical Sciences (CIOMS)
Formaat:	Boek
Taal:	English
Gepubliceerd in:	Geneva Council for International Organizations of Medical Sciences (CIOMS) 1998
Onderwerpen:	Drugs Pharmaceutic Preparations Pharmaceutical Products Preparations, Pharmaceutical
Online toegang:	Visit NHRC Library
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Martindale: the complete drug reference
door: Parfitt, Kathleen
Gepubliceerd in: (1999)

WHO drug information.
Gepubliceerd in: (2000)

WHO expert committee on specifications for pharmaceutical preparations
Gepubliceerd in: (2006)

International nonproprietary names (INN) for pharmaceutical substances : lists 1-65 of proposed INN and lists 1-31 of recommended INN : cumulative list no. 8 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées : liste récapitulative no. 8.
Gepubliceerd in: (1992)

WHO expert committee on specifications for pharmaceutical preparations
Gepubliceerd in: (2011)

WHO Expert Committee on Specifications for Pharmaceutical Preparations
Gepubliceerd in: (2012)

USP DI. Approved drug products and legal requirements.
Gepubliceerd in: (1995)

Where there are no pharmacists : a guide to managing medicines for all health workers /
door: Andersson, Sarah
Gepubliceerd in: (2010)

Managing drug supply : the selection, procurement, distribution, and use of pharmaceuticals. the selection, procurement, distribution, and use of pharmaceuticals.
Gepubliceerd in: (1997)

Pharmacology : a patient-centered nursing process approach /
door: Kee, Joyce LeFever, et al.

Drug calculations : ratio and proportion problems for clinical practice /
door: Seltzer, Meta Brown, et al.

Effective drug regulation a multicountry study /
door: Ratanawijitrasin, Sauwakon
Gepubliceerd in: (2002)

WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /

Preparation of hazardous waste inventory
door: DEVS Consult Nepal (P) Ltd.
Gepubliceerd in: (2013)

Client satisfaction and quality of curative services for sick children in Nepal: further analysis of the 2015 Nepal Health Facility Survey: DHS further analysis reports No. 114.
door: Acharya,Kiran
Gepubliceerd in: (2018)

Regulatory Situation of Herbal Medicines
Gepubliceerd in: (1998)

A text book of pharmacognosy.
door: Raut, Bechan, et al.
Gepubliceerd in: (2007)

Status of Ayurvedic Medicines Available in the Markets of Nepal
door: Adhikari, SM, et al.
Gepubliceerd in: (2016)

The Selection and Use of Essential Medicines Reports of the WHO Expert Committee on the Selection and Use of Essential Medicines and the 3rd WHO Model list of essential medicines for children
Gepubliceerd in: (2012)

AHFS drug information 2000
door: Snow, Elaine, K
Gepubliceerd in: (2000)

Safety requirements for the first use of new drugs and diagnostic agents in man : a review of safety issues in early clinical trials of drugs.
Gepubliceerd in: (1983)

Final Report on Development of Profile of Toxic Waste Products in Nepal
door: Nepal Health Research Council (NHRC), et al.
Gepubliceerd in: (2013)

Serotyping and antibiotic resistance profile of common bacterial isolates causing gastroenteritis.
door: Yadav, Raju
Gepubliceerd in: (2016)

Ensuring balance in national policies on control substances: Guidelines for availability and accessibility of controlled medicines
Gepubliceerd in: (2011)

Clinical trials: study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines
door: Brody, Tom
Gepubliceerd in: (2016)

Evaluation of certain veterinary drug residues in food
Gepubliceerd in: (2000)

WHO Expert Committee on biological standardization sixty-fourth meeting report /

Study on the Projection and Management of Health Care Professionals for the Next Ten Years
door: Aryal, BK, et al.
Gepubliceerd in: (2016)

Impact of educational intervention on knowledge and practice of safety precaution of cytotoxic drugs administration among nurse.
door: Pande, Sarala
Gepubliceerd in: (2011)

Status of Ayurvedic medicines available in the markets of Nepal
door: Adhikari, Shyam Mani
Gepubliceerd in: (2008)

Status of Ayurvedic Medicines Available in the Markets of Nepal
door: Adhikari, Shyam Mani, Dr.
Gepubliceerd in: (2012)

Evaluation of certain veterinary drug residues in food: Forty- second report of the joint FAO/WHO expert committee on food additives
Gepubliceerd in: (1995)

Fundamentals of Clinical Trials /
door: Friedman, Lawrence M, et al.
Gepubliceerd in: (2015)

Evaluation of certain veterinary drug residues in food : seventy-fifth[75th] report of the Joint FAO/WHO Expert Committee on Food Additives
Gepubliceerd in: (2012)

The use of essential drugs : ninth report of the WHO Expert Committee (including the revised Model list of essential drugs).
Gepubliceerd in: (2000)

Drug policy in the Americas
door: Smith, Peter H.
Gepubliceerd in: (1992)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Gepubliceerd in: (2011)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Gepubliceerd in: (2011)

Iodized salt social marketing campaign (ISMAC): Baseline Study
door: Poudel, Krishna Prasad
Gepubliceerd in: (2015)

Public Health Care Expenditures in Nepal: Review, Analysis and Assessment
door: Maskay, NM, et al.
Gepubliceerd in: (2016)